← Eichor
Study identifier: NCT05675735 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Condition: Problems Related to Social Environment  ·  Sponsor: NYU Langone Health

PhaseNA
Planned participants318
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Using a stepped-wedge randomized controlled trial, the study will test whether a clinic-level multidimensional intervention conducted in 36 opioid treatment programs (OTPs) will improve clinical decision making, regulatory confusion, legal liability concerns, capacity for clinical practice change, and financial barriers to take- home dosing (THD) for methadone as compared to treatment as usual.

This description comes directly from the study's public registry record.

Talk to the study team

Charles Neighbors, PhD  ·  646-501-3875  ·  Charles.Neighbors@nyulangone.org

Beth Knopf, MPH  ·  646-481-2528  ·  Elizabeth.Knopf@nyulangone.org

Always discuss trial participation with your own doctor first.

Locations (4)

University of ConnecticutStorrs, Connecticut, United StatesRecruiting
University at BuffaloBuffalo, New York, United StatesRecruiting
NYU Langone HealthNew York, New York, United StatesRecruiting
Weill Cornell Medical CollegeNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05675735